Display options
Share it on

JIMD Rep. 2017;31:101-106. doi: 10.1007/8904_2016_543. Epub 2016 May 21.

Glycine N-Methyltransferase Deficiency: A Member of Dysmethylating Liver Disorders?.

JIMD reports

Ivo Barić, Sahin Erdol, Halil Saglam, Mila Lovrić, Robert Belužić, Oliver Vugrek, Henk J Blom, Ksenija Fumić

Affiliations

  1. Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia. [email protected].
  2. School of Medicine, University of Zagreb, Zagreb, Croatia. [email protected].
  3. Division of Metabolism, Department of Pediatrics, Uludag University Faculty of Medicine, Gorukle, Bursa, Turkey.
  4. Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia.
  5. Department of Molecular Medicine, Institute Ru?er Boškovi?, Zagreb, Croatia.
  6. Department of General Pediatrics, Adolescent Medicine and Neonatology, University Medical Centre Freiburg, Freiburg, Germany.

PMID: 27207470 PMCID: PMC5388635 DOI: 10.1007/8904_2016_543

Abstract

Glycine N-methyltransferase deficiency is an inherited disorder of methionine metabolism, reported so far in only four patients and characterised by permanent hypermethioninemia. This disorder has been considered as probably benign because moderate hepatomegaly in two patients was the only obvious symptom and mild to moderate elevation of aminotransferases the only laboratory abnormality. Our experience with the current novel patient points out that this disease, due to very high hypermethioninemia, is not harmless and that there may be diagnostic pitfalls in interpretation of biochemical hallmarks of the disease. Since the first description of glycine N-methyltransferase deficiency, other disorders of this metabolic pathway affecting the liver have been reported pointing to dysmethylation as the common pathogenetic mechanism. Therefore, we suggest the whole group to be named dysmethylating liver diseases.

Keywords: Glycine-N-methyltransferase deficiency; Hypermethioninemia; Inherited liver disease; Methylation disorders

References

  1. Am J Hum Genet. 2011 Oct 7;89(4):507-15 - PubMed
  2. J Inherit Metab Dis. 2003;26(8):745-59 - PubMed
  3. J Biol Chem. 2009 Aug 21;284(34):22507-11 - PubMed
  4. Int J Cancer. 1998 Mar 2;75(5):787-93 - PubMed
  5. Mol Genet Metab. 2012 Feb;105(2):228-36 - PubMed
  6. Clin Chem. 2005 Aug;51(8):1487-92 - PubMed
  7. J Pediatr. 2004 Apr;144(4):545-8 - PubMed
  8. Hepatology. 2007 Nov;46(5):1413-25 - PubMed
  9. Mol Genet Metab. 2015 Dec;116(4):269-74 - PubMed
  10. J Inherit Metab Dis. 2016 Mar;39(2):273-83 - PubMed
  11. J Inherit Metab Dis. 2001 Aug;24(4):448-64 - PubMed
  12. J Clin Invest. 1996 Aug 15;98(4):1021-7 - PubMed
  13. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12 ):4234-9 - PubMed
  14. Am J Med Genet C Semin Med Genet. 2011 Feb 15;157C(1):3-32 - PubMed
  15. Orphanet J Rare Dis. 2015 Aug 20;10:99 - PubMed
  16. Biochem J. 2006 Dec 1;400(2):245-53 - PubMed
  17. AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10 ):2705-6 - PubMed
  18. Transgenic Res. 2006 Jun;15(3):393-7 - PubMed
  19. J Hepatol. 2000 Dec;33(6):907-14 - PubMed
  20. Am J Physiol Renal Physiol. 2005 Oct;289(4):F786-92 - PubMed
  21. Hepatology. 2008 Apr;47(4):1191-9 - PubMed

Publication Types